These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2634374)

  • 1. [A clinical evaluation of rush immunotherapy in adult patients with severe bronchial asthma].
    Nagata M; Yamamoto H; Tabe K; Tanaka K; Kimura I; Sakamoto K; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1989 Dec; 38(12):1319-26. PubMed ID: 2634374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical evaluation of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M
    Arerugi; 1998 Apr; 47(4):426-33. PubMed ID: 9621470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A trial of new protocol of rush immunotherapy with standardized mite antigen].
    Tabe K; Mizukoshi T; Nishi Y; Noguchi T; Shuh S; Kobayashi Y; Shibasaki M; Yamamoto H; Nagata M; Sakamoto Y; Matsuo H
    Arerugi; 1999 May; 48(5):526-32. PubMed ID: 10390900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M; Tanaka K
    Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of rapid injection immunotherapy by antigen specific IgE and IgG4 antibodies].
    Satoh Y; Sugimoto K; Kuroki H; Fuzimoto N; Suzuki H
    Arerugi; 1989 Mar; 38(3):246-53. PubMed ID: 2751431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The analysis of factors contributing to the safety and efficacy of rush immunotherapy in bronchial asthma].
    Nagata M; Tabe K; Yamamoto H; Maruo H; Kiuch H; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1993 May; 42(5):628-34. PubMed ID: 8323461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
    Ebner H; Neuchrist C; Havelec L; Kraft D
    Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
    Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
    Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
    Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
    Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predicting the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics by multiple quantification analysis type II].
    Soda R; Okada C; Takahashi K; Katagi S; Kanehiro A; Kimura G; Okamoto S; Tada S; Kimura I
    Arerugi; 1993 Dec; 42(12):1771-5. PubMed ID: 8110037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
    Zietkowski Z
    Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desensitization immunotherapy on patients with mite-positive bronchial asthma using purified mite feces antigen fractions].
    Asaoku Y; Jyo T; Mochiduki N; Kodomari Y; Kuwabara M; Yoshizane T; Shigeta S; Ono K; Tsuboi S; Ootsuka T
    Arerugi; 1995 Jul; 44(7):692-700. PubMed ID: 7575135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites].
    Zietkowski Z
    Pol Merkur Lekarski; 1999 May; 6(35):236-8. PubMed ID: 10437389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allergen-specific immune therapy in the treatment of asthma].
    Malling HJ
    Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of house dust mite extract in bronchial asthma. Mite Allergy Subcommittee of the Research Committee of the British Thoracic Association.
    Br J Dis Chest; 1979 Jul; 73(3):260-70. PubMed ID: 399857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
    Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T; Mayer J
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of lymphocyte activation on late asthmatic response in adult asthma].
    Kanehiro A; Takahashi K; Tada S; Soda R; Inoki A; Tanimoto Y; Kimura G; Okamoto S; Okano T; Koto N
    Arerugi; 1992 Jul; 41(7):739-48. PubMed ID: 1444826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antigen specific IgE responses in Japanese asthmatics and non-asthmatics].
    Takahashi D; Hizawa N; Maeda Y; Fukui Y; Nishimura M
    Arerugi; 2004 Oct; 53(10):1071-8. PubMed ID: 15672726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG, IgA, IgM and IgE serum levels in asthmatic patients sensitive to house dust and mite allergens after two-year specific immunotherapy.
    Szymański W; Chyrek-Borowska S; Obrzut D
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):381-7. PubMed ID: 6534314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.